293 related articles for article (PubMed ID: 35126054)
21. Novel drug delivery systems for inner ear protection and regeneration after hearing loss.
Richardson RT; Wise AK; Andrew JK; O'Leary SJ
Expert Opin Drug Deliv; 2008 Oct; 5(10):1059-76. PubMed ID: 18817513
[TBL] [Abstract][Full Text] [Related]
22. Gene and drug delivery system and potential treatment into inner ear for protection and regeneration.
Kanzaki S
Front Pharmacol; 2014; 5():222. PubMed ID: 25339903
[TBL] [Abstract][Full Text] [Related]
23. miR-204 suppresses cochlear spiral ganglion neuron survival in vitro by targeting TMPRSS3.
Li Y; Peng A; Ge S; Wang Q; Liu J
Hear Res; 2014 Aug; 314():60-4. PubMed ID: 24924414
[TBL] [Abstract][Full Text] [Related]
24. Protection of spiral ganglion neurons from degeneration using small-molecule TrkB receptor agonists.
Yu Q; Chang Q; Liu X; Wang Y; Li H; Gong S; Ye K; Lin X
J Neurosci; 2013 Aug; 33(32):13042-52. PubMed ID: 23926258
[TBL] [Abstract][Full Text] [Related]
25. Pleiotrophin increases neurite length and number of spiral ganglion neurons in vitro.
Bertram S; Roll L; Reinhard J; Groß K; Dazert S; Faissner A; Volkenstein S
Exp Brain Res; 2019 Nov; 237(11):2983-2993. PubMed ID: 31515588
[TBL] [Abstract][Full Text] [Related]
26. Structural and Ultrastructural Changes to Type I Spiral Ganglion Neurons and Schwann Cells in the Deafened Guinea Pig Cochlea.
Wise AK; Pujol R; Landry TG; Fallon JB; Shepherd RK
J Assoc Res Otolaryngol; 2017 Dec; 18(6):751-769. PubMed ID: 28717876
[TBL] [Abstract][Full Text] [Related]
27. Insulin-like growth factor 1 promotes cochlear synapse regeneration after excitotoxic trauma in vitro.
Yamahara K; Asaka N; Kita T; Kishimoto I; Matsunaga M; Yamamoto N; Omori K; Nakagawa T
Hear Res; 2019 Mar; 374():5-12. PubMed ID: 30682699
[TBL] [Abstract][Full Text] [Related]
28. [The role of the spiral ganglion neurons in cochlear implants. Today and in future regenerative inner ear treatment].
Euteneuer S; Hansen S; Ryan AF
HNO; 2008 Apr; 56(4):457-60. PubMed ID: 18351308
[TBL] [Abstract][Full Text] [Related]
29. Oriented polyaniline/poly-l-lactic acid/gelatin nanofiber scaffolds promote outgrowth of spiral ganglion neurons.
Liu L; Chen M; Zhang J; Li H; Li Z; Song J; Ma S; Wang Y; Lou X
J Biomed Mater Res A; 2024 May; 112(5):700-709. PubMed ID: 37962013
[TBL] [Abstract][Full Text] [Related]
30. Age-related hearing loss: GABA, nicotinic acetylcholine and NMDA receptor expression changes in spiral ganglion neurons of the mouse.
Tang X; Zhu X; Ding B; Walton JP; Frisina RD; Su J
Neuroscience; 2014 Feb; 259():184-93. PubMed ID: 24316061
[TBL] [Abstract][Full Text] [Related]
31. Does cochlear implantation and electrical stimulation affect residual hair cells and spiral ganglion neurons?
Coco A; Epp SB; Fallon JB; Xu J; Millard RE; Shepherd RK
Hear Res; 2007 Mar; 225(1-2):60-70. PubMed ID: 17258411
[TBL] [Abstract][Full Text] [Related]
32. Stem cell transplantation via the cochlear lateral wall for replacement of degenerated spiral ganglion neurons.
Zhang PZ; He Y; Jiang XW; Chen FQ; Chen Y; Shi L; Chen J; Chen X; Li X; Xue T; Wang Y; Mi WJ; Qiu JH
Hear Res; 2013 Apr; 298():1-9. PubMed ID: 23403006
[TBL] [Abstract][Full Text] [Related]
33. Long-term delivery of brain-derived neurotrophic factor (BDNF) from nanoporous silica nanoparticles improves the survival of spiral ganglion neurons in vitro.
Schmidt N; Schulze J; Warwas DP; Ehlert N; Lenarz T; Warnecke A; Behrens P
PLoS One; 2018; 13(3):e0194778. PubMed ID: 29584754
[TBL] [Abstract][Full Text] [Related]
34. Recent advances in the development and function of type II spiral ganglion neurons in the mammalian inner ear.
Zhang KD; Coate TM
Semin Cell Dev Biol; 2017 May; 65():80-87. PubMed ID: 27760385
[TBL] [Abstract][Full Text] [Related]
35. Type I vs type II spiral ganglion neurons exhibit differential survival and neuritogenesis during cochlear development.
Barclay M; Ryan AF; Housley GD
Neural Dev; 2011 Oct; 6():33. PubMed ID: 21989106
[TBL] [Abstract][Full Text] [Related]
36. Pou3f4-expressing otic mesenchyme cells promote spiral ganglion neuron survival in the postnatal mouse cochlea.
Brooks PM; Rose KP; MacRae ML; Rangoussis KM; Gurjar M; Hertzano R; Coate TM
J Comp Neurol; 2020 Aug; 528(12):1967-1985. PubMed ID: 31994726
[TBL] [Abstract][Full Text] [Related]
37. Reprogramming Glia Into Neurons in the Peripheral Auditory System as a Solution for Sensorineural Hearing Loss: Lessons From the Central Nervous System.
Meas SJ; Zhang CL; Dabdoub A
Front Mol Neurosci; 2018; 11():77. PubMed ID: 29593497
[TBL] [Abstract][Full Text] [Related]
38. Bisphosphonate-Linked TrkB Agonist: Cochlea-Targeted Delivery of a Neurotrophic Agent as a Strategy for the Treatment of Hearing Loss.
Kempfle JS; Nguyen K; Hamadani C; Koen N; Edge AS; Kashemirov BA; Jung DH; McKenna CE
Bioconjug Chem; 2018 Apr; 29(4):1240-1250. PubMed ID: 29485861
[TBL] [Abstract][Full Text] [Related]
39. Perspectives for the treatment of sensorineural hearing loss by cellular regeneration of the inner ear.
Almeida-Branco MS; Cabrera S; Lopez-Escamez JA
Acta Otorrinolaringol Esp; 2015; 66(5):286-95. PubMed ID: 25459416
[TBL] [Abstract][Full Text] [Related]
40. Generation of human otic neuronal organoids using pluripotent stem cells.
Sun G; Tang M; Wang X; Li D; Liu W; Qi J; Wang H; Hu B
Cell Prolif; 2023 May; 56(5):e13434. PubMed ID: 36825797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
